News Article -- March 28, 2007

Maryland: The Competitive Advantage in Biodefense and Infectious Disease Research

This is a recording of an event that already occurred.

Learn about the economic development incentives in Maryland, and how companies can benefit by locating in this hotspot.

Hear the stories behind Maryland companies in the biodefense and public health arenas so topical today (e.g. pandemic flu, anthrax, etc.) and the value they have realized in a Maryland location.

Companies will discuss their mission, history and future outlook in light of their relationships with the state of Maryland.

After these companies present their stories, the Secretary of Maryland Department of Business and Economic Development will enumerate the assets and advantages unique to Maryland, and how your company can take advantage of them.

Speakers

Larry Mahan, Ph.D.
Director of Biosciences,
Maryland Department of Business and Economic Development

Robert V. House, Ph.D.
President and Chief Scientific Officer,
DynPort Vaccine Company LLC

Michael J. Langford, DVM, Ph.D.
President,
Emergent Product Development Gaithersburg Inc.

Darryl D. Rekemeyer
Director,
Fort Detrick Business Development Office

Host:

John Carroll,
Editor,
FierceBiotech
__________________________________________________________________

Click here to listen to the webinar.
Listening to the webinar requires registration.